🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 778.57 +0.6% NASDAQ 100: 751.27 +0.5% Dow Jones: 534.08 -0.5%

Enclave Advisors - Q2 2026 13F Filings

EN

Enclave Advisors LLC

CIK: 0001836110
Address: Texas Austin 3600 N. Capital Of Texas Hwy Bldgb, Suite 180
$790.39 M
Portfolio Value
133
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 07/14/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026
1. VGT Vanguard Information Technology Etf
+$28.06 M
2. VO Vanguard Mid-Cap Etf
+$25.6 M
3. VUG Vanguard Growth Etf
+$17.35 M
4. SCHV Schwab Us Large-Cap Value Etf
+$11.25 M
5. QQQM Invesco Nasdaq 100 Etf
+$9.78 M

Top Sells

Q2 2026
1. VIG Vanguard Dividend Appreciation Etf
−$16.98 M
2. VGIT Vanguard Intermediate-Term Treasury Etf
−$14.7 M
3. SCHD Schwab Us Dividend Equity Etf
−$4.61 M
4. IGSB Ishares 1-5 Year Investment Grade Corporate Bond Etf
−$1.85 M
5. IWM Ishares Russell 2000 Etf
−$1.51 M

Asset Allocation

Stocks/ETFs
+9.39%
$766.4 M 96.97%
Options
-17.39%
$23.05 M 2.92%
Debt
$0 0.00%
Other
-0.67%
$933,538 0.12%

Sector Allocation (Stocks)

Enclave Advisors Q2 2026 Filing Summary

Enclave Advisors LLC filed its 13F report for Q2 2026 on July 14, 2026. The portfolio totaled 790.39 M reflecting a +8.35% change from the prior quarter, spanning 133 assets. The top 10 holdings comprised 52.8% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 13 new positions and 12 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Enclave Advisors’s Q2 2026 Filing

Enclave Advisors submitted their Form 13F-HR for the Q2 2026 period on 07/14/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Enclave Advisors reported a managed portfolio value of 790.39 M, consisting of 133 individual positions.

This page displays the raw filing documents. To see which stocks Enclave Advisors bought or sold during Q2 2026, please visit Enclave Advisors's Portfolio Analysis page.